Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy

Hormones and Cancer

Volumn 7, Issue 5-6, 2016, Pages 305-315

  Oh, Hannah ^a,b   Khodr, Zeina G ^a   Sherman, Mark E ^a   Palakal, Maya ^a   Pfeiffer, Ruth M ^a   Linville, Laura ^a   Geller, Berta M ^c   Vacek, Pamela M ^c   Weaver, Donald L ^c   Chicoine, Rachael E ^c   Falk, Roni T ^a   Horne, Hisani N ^a   Papathomas, Daphne ^a   Patel, Deesha A ^a   Xiang, Jackie ^a   Xu, Xia ^d   Veenstra, Timothy ^d   Hewitt, Stephen M ^a   Shepherd, John A ^e   Brinton, Louise A ^a   Figueroa, Jonine D ^a,f   Gierach, Gretchen L ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b The University of Vermont ^*  (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

16 EPIESTRIOL; 16 KETOESTRADIOL; 16A HYDROXYESTRONE; 17 EPIESTRIOL; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; 2 METHOXYESTRADIOL; 2 METHOXYESTRONE; 2 METHOYXESTRONE; 4 HYDROXYESTRONE; 4 METHOXYESTRADIOL; 4 METHOXYESTRONE; CATECHOL DERIVATIVE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTRONE; UNCLASSIFIED DRUG; 2-HYDROXYESTRONE; 4-HYDROXYESTRONE; ESTRONE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER RISK; CARCINOMA IN SITU; CROSS-SECTIONAL STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; IMAGE GUIDED BIOPSY; INVASIVE CARCINOMA; INVOLUTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TERMINAL DUCT LOBULAR UNIT INVOLUTION; BLOOD; BREAST; BREAST NEOPLASMS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; BREAST; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; HUMANS; HYDROXYESTRONES; IMAGE-GUIDED BIOPSY; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; TANDEM MASS SPECTROMETRY;

EID: 84965045412     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-016-0265-2     Document Type: Article

References (44)

1. Key T, Appleby P, Barnes I, Reeves G, Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606–616
2. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, Dorgan JF, Dossus L, Dowsett M, Eliassen AH, Fortner RT, Hankinson SE, Helzlsouer KJ, Hoff man-Bolton J, Comstock GW, Kaaks R, Kahle LL, Muti P, Overvad K, Peeters PH, Riboli E, Rinaldi S, Rollison DE, Stanczyk FZ, Trichopoulos D, Tworoger SS, Vineis P (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14(10):1009–1019. doi:10.1016/S1470-2045(13)70301-2
3. Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, Sue LY, Buys SS, Isaacs C, Keefer LK, Veenstra TD, Berg CD, Hoover RN, Ziegler RG (2012) Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 104(4):326–339. doi:10.1093/jnci/djr531
4. Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV Jr, Cauley JA, Hue TF, Lacroix A, Falk RT, Pfeiffer RM, Fuhrman BJ, Veenstra TD, Xu X, Brinton LA (2014) Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B∼FIT. Carcinogenesis 35(2):346–355. doi:10.1093/carcin/bgt367
5. Falk RT, Brinton LA, Dorgan JF, Fuhrman BJ, Veenstra TD, Xu X, Gierach GL (2013) Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res BCR 15(2):R34. doi:10.1186/bcr3416
6. Santen RJ, Yue W, Wang JP (2015) Estrogen metabolites and breast cancer. Steroids 99(Pt A):61–66. doi:10.1016/j.steroids.2014.08.003
7. Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W (2009) Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci 1155:132–140. doi:10.1111/j.1749-6632.2008.03685.x
8. Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH (2003) Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 87(1):1–25
9. Seeger H, Wallwiener D, Kraemer E, Mueck AO (2006) Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 54(1):72–77. doi:10.1016/j.maturitas.2005.08.010
10. Kono S, Merriam GR, Brandon DD, Loriaux DL, Lipsett MB, Fujino T (1983) Radioimmunoassay and metabolic clearance rate of catecholestrogens, 2-hydroxyestrone and 2-hydroxyestradiol in man. J Steroid Biochem 19(1B):627–633
11. Pfeiffer E, Graf E, Gerstner S, Metzler M (2006) Stimulation of estradiol glucuronidation: a protective mechanism against estradiol-mediated carcinogenesis? Mol Nutr Food Res 50(4–5):385–389. doi:10.1002/mnfr.200500198
12. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents—DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75–93
13. Yager JD (2000) Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 27:67–73
14. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55(2):231–273
15. Hutson SW, Cowen PN, Bird CC (1985) Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 38(3):281–287
16. Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM (2009) Lobule type and subsequent breast cancer risk: results from the Nurses’ Health Studies. Cancer 115(7):1404–1411. doi:10.1002/cncr.24167
17. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ 3rd, Goode EL, Visscher DW (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98(22):1600–1607. doi:10.1093/jnci/djj439
18. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC (2009) Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 27(35):5893–5898. doi:10.1200/JCO.2008.21.5079
19. Figueroa J, Pfeiffer RM, Brinton L, Palakal MM, Degnim AC, Radisky DC, Hartmann LC, Frost C, Stallings Mann ML, Papathomas D, Hewitt S, Visscher D, Sherman M (2015) Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease. Cancer Res. doi:10.1158/1538-7445.AM2015-4682.
20. Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, Yang XR, Papathomas D, Visscher D, Mies C, Degnim AC, Anderson WF, Hewitt S, Khodr ZG, Clare SE, Storniolo AM, Sherman ME (2014) Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst. doi:10.1093/jnci/dju286
21. Khodr ZG, Sherman ME, Pfeiffer RM, Gierach GL, Brinton LA, Falk RT, Patel DA, Linville LM, Papathomas D, Clare SE, Visscher DW, Mies C, Hewitt SM, Storniolo AM, Rosebrock A, Caban JJ, Figueroa JD (2014) Circulating sex hormones and terminal duct lobular unit involution of the normal breast. Cancer Epidemiol Biomarkers Prev 23(12):2765–2773. doi:10.1158/1055-9965.EPI-14-0667
22. Gierach GL, Geller BM, Shepherd JA, Patel DA, Vacek PM, Weaver DL, Chicoine RE, Pfeiffer RM, Fan B, Mahmoudzadeh AP, Wang J, Johnson JM, Herschorn SD, Brinton LA, Sherman ME (2014) Comparison of mammographic density assessed as volumes and areas among women undergoing diagnostic image-guided breast biopsy. Cancer Epidemiol Biomarkers Prev 23(11):2338–2348. doi:10.1158/1055-9965.EPI-14-0257
23. Malkov S, Wang J, Kerlikowske K, Cummings SR, Shepherd JA (2009) Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. Med Phys 36(12):5525–5536
24. Gierach GL, Patel DA, Falk RT, Pfeiffer RM, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Shepherd JA, Mahmoudzadeh AP, Wang J, Fan B, Herschorn SD, Xu X, Veenstra T, Fuhrman B, Sherman ME, Brinton LA (2015) Relationship of serum estrogens and metabolites with area and volume mammographic densities. Horm Cancer 6(2–3):107–119. doi:10.1007/s12672-015-0216-3
25. Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG (2007) Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 79(20):7813–7821. doi:10.1021/ac070494j
26. Gierach GL, Patel DA, Pfeiffer RM, Figueroa JD, Linville L, Papathomas D, Johnson JM, Chicoine RE, Herschorn SD, Shepherd JA, Wang J, Malkov S, Vacek PM, Weaver DL, Fan B, Mahmoudzadeh AP, Palakal M, Xiang J, Oh H, Horne HN, Sprague BL, Hewitt SM, Brinton LA, Sherman ME (2016) Relationship of terminal duct lobular unit involution of the breast with area and volume mammographic densities. Cancer Prev Res 9(2):149–158. doi:10.1158/1940-6207.CAPR-15-0282
27. Rosebrock A, Caban JJ, Figueroa J, Gierach G, Linville L, Hewitt S, Sherman M (2013) Quantitative analysis of TDLUs using adaptive morphological shape techniques. Proc SPIE Int Soc Opt Eng 8676. doi:10.1117/12.2006619
28. Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, Lissowska J, Peplonska B, Brinton L, Garcia-Closas M, Sherman ME (2012) Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res BCR 14(2):R64. doi:10.1186/bcr3170
29. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, Visscher DW, Reynolds C, Frost MH, Hartmann LC (2010) Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst 102(22):1716–1723. doi:10.1093/jnci/djq414
30. Fuhrman BJ, Xu X, Falk RT, Dallal CM, Veenstra TD, Keefer LK, Graubard BI, Brinton LA, Ziegler RG, Gierach GL (2014) Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry. Cancer Epidemiol Biomarkers Prev 23(12):2649–2657. doi:10.1158/1055-9965.EPI-14-0438
31. Long JS (1997) Count outcomes: regression models for counts, 1st edn. SAGE Publications, Inc., Thousand Oaks
32. Zeileis A (2004) Econometric computing with HC and HAC covariance matrix estimators. J Stat Softw 11(10):1–17
33. Zeileis A (2006) Object-oriented computation of sandwich estimators. J Stat Softw 16(9):1–16
34. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548–2556. doi:10.1210/jc.2004-0395
35. Barnea ER, MacLusky NJ, Naftolin F (1983) Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity. Steroids 41(5):643–656
36. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6(10):798–808. doi:10.1016/S1470-2045(05)70390-9
37. Bertrand KA, Eliassen AH, Hankinson SE, Gierach GL, Xu X, Rosner B, Ziegler RG, Tamimi RM (2012) Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat 136(1):277–287. doi:10.1007/s10549-012-2240-0
38. Fuhrman BJ, Brinton LA, Pfeiffer RM, Xu X, Veenstra TD, Teter BE, Byrne C, Dallal CM, Barba M, Muti PC, Gierach GL (2012) Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study. Cancer Epidemiol Biomarkers Prev 21(9):1582–1591. doi:10.1158/1055-9965.EPI-12-0247
39. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM (2010) Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 28(13):2207–2212. doi:10.1200/JCO.2009.23.4120
40. Boyd NF, Lockwood GA, Martin LJ, Knight JA, Byng JW, Yaffe MJ, Tritchler DL (1998) Mammographic densities and breast cancer risk. Breast Dis 10(3–4):113–126
41. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10(3):243–248
42. Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH, Greenhut SF (2002) Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 67(3–4):151–158
43. McShane LM, Dorgan JF, Greenhut S, Damato JJ (1996) Reliability and validity of serum sex hormone measurements. Cancer Epidemiol Biomarkers Prev 5(11):923–928
44. Rinaldi S, Dechaud H, Biessy C, Morin-Raverot V, Toniolo P, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Secreto G, Ciampi A, Riboli E, Kaaks R (2001) Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol Biomarkers Prev 10(7):757–765